To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05497453
Title A Phase 1/2 Study to Evaluate OTX-2002 in Patients With Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association With the MYC Oncogene (MYCHELANGELO I)
Acronym MYCHELANGELO I
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Omega Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of Florida Health Cancer Center Gainesville Florida 32610 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Ochsner Clinic Foundation New Orleans Louisiana 70121 United States Details
Stephenson Cancer Center at Oklahoma University Oklahoma City Oklahoma 73104 United States Details
Fred Hutch / University of Washington Seattle Washington 98109 United States Details
Prince of Wales Hospital Hong Kong Hong Kong Details
Queen Mary Hospital Hong Kong Hong Kong Details
Asan Medical Center Seoul Korea, Republic of Details
Seoul National University Hospital Seoul Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul Korea, Republic of Details
National Cancer Center Singapore Singapore Singapore Details
National University Hospital Singapore Singapore Details
National Cheng Kung University Hospital Tainan Taiwan Details
National Taiwan University Hospital Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field